News from cogent biosciences, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 06, 2021, 07:00 ET Cogent Biosciences Announces Creation of Cogent Research Team

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Mar 16, 2021, 07:00 ET Cogent Biosciences Reports Fourth Quarter 2020 and Full Year 2020 Financial Results

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Feb 22, 2021, 07:00 ET Cogent Biosciences Appoints Accomplished Finance Executive Todd E. Shegog to its Board of Directors

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Feb 18, 2021, 07:00 ET Cogent Biosciences to Present at Virtual 10th Annual SVB Leerlink Global Healthcare Conference 2021

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Feb 11, 2021, 07:00 ET Cogent Biosciences to Present at LifeSci Partners Virtual Precision Oncology Day 2021

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Dec 04, 2020, 17:16 ET Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares

Cogent Biosciences, Inc. ("Cogent") (NASDAQ: COGT), a biotechnology company focused on developing precision therapies for genetically defined...

Dec 01, 2020, 23:08 ET Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Nov 30, 2020, 16:01 ET Cogent Biosciences Announces $60.0 Million Public Offering of Shares of Common Stock

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Nov 30, 2020, 07:00 ET Cogent Biosciences Appoints Brad Barnett as Chief Technology Officer

Cogent Biosciences, Inc. ("Cogent") (NASDAQ: COGT), a biotechnology company focused on developing precision therapies for genetically defined...

Nov 20, 2020, 07:00 ET Cogent Biosciences to Participate in 3rd Annual Evercore ISI HealthCONx Virtual Conference

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Nov 18, 2020, 09:00 ET Cogent Biosciences Announces Final Results from PLX9486 Phase 1/2 Study in Advanced GIST Patients at CTOS 2020

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Nov 12, 2020, 16:30 ET Cogent Biosciences to Present at Jefferies 2020 Virtual London Healthcare Conference

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Nov 09, 2020, 07:00 ET Cogent Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Updates

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Nov 05, 2020, 07:00 ET Cogent Biosciences to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today...

Oct 26, 2020, 07:00 ET Cogent Biosciences Appoints Andrew Robbins as Chief Executive Officer

Cogent Biosciences, Inc. ("Cogent") (NASDAQ: COGT), a biotechnology company focused on developing precision therapies for genetically defined...

Oct 05, 2020, 08:58 ET Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress

Unum Therapeutics Inc. ("Unum") (NASDAQ: UMRX), a biotechnology company focused on developing precision therapies for genetically defined diseases,...